Key TakeawaysChina's State Council has announced a significant acceleration in the review and approval process for breakthrough therapeutic drugs, signaling robust government support for pharmaceutical innovation and potentially faster market access for novel treatments. This policy is poised to benefit domestic biotech and pharmaceutical companies, streamlining their path from development to commercialization.The Cabinet also committed to actively promoting green trade and further facilitating cross-border ...